These premium research reagents include low density lipoprotein (LDL), high density lipoprotein (HDL), very low density lipoprotein (VLDL), and lipid depleted serum
Kalen Biomedical HAS announced the introduction of a new line of lipoproteins for cardiovascular research.
Lipoproteins are available in their oxidiSed and acetylated forms.
Lipoprotein probes are available with either a fluorescent or biotin label.
"We are pleased to supply these lipoproteins to the cardiovascular research community worldwide" said Kathy Foxx, President of Kalen Biomedical.
"Our mission is to advance research into cardiovascular disease by providing researchers with the research reagents they need".
Because Kalen products are manufactured with a proprietary manufacturing process and stringent quality controls, the products are more stable than those available from other commercial suppliers.
Flexible production protocols enhance Kalen's ability to deliver researchers what they need and when they need it.
Since it was founded in 2007, Kalen Biomedical has supplied cardiovascular research reagents to customers in major pharmaceutical and biotechnology companies as well as universities and other research institutions.
